Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015; 67: 460-7

被引：2

作者：

Martin, Neil E. ^{[1
,2
]}

Stowell, Caleb ^{[1
]}

Huland, Hartwig ^{[3
]}

机构：

[1] Int Consortium Hlth Outcomes Measurement, Cambridge, MA USA

[2] Harvard Univ, Sch Med, Dana Farber Brigham & Womens Canc Ctr, Dept Radiat Oncol, Boston, MA USA

[3] Univ Med Ctr Hamburg Eppendorf, Martini Klin, Hamburg, Germany

来源：

EUROPEAN UROLOGY | 2015年 / 68卷 / 06期

关键词：

D O I：

10.1016/j.eururo.2015.08.016

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E125 / E126

页数：2

共 6 条

[1] Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015; 67: 460-7
MacLennan, Steven
Williamson, Paula R.
Lam, Thomas B.
[J]. EUROPEAN UROLOGY, 2015, 68 (06) : E123 - E124
[2] Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7
Wittmann, Daniela
Skolarus, Ted A.
[J]. EUROPEAN UROLOGY, 2016, 69 (06) : E125 - E126
[3] Reply to Daniela Wittmann, Ted A. Skolarus' Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460-7
Martin, Neil E.
Stowell, Caleb
[J]. EUROPEAN UROLOGY, 2016, 69 (06) : E127 - E127
[4] Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87
Bayne, Christopher E.
Williams, Stephen B.
Chapin, Brian F.
[J]. EUROPEAN UROLOGY, 2017, 71 (02) : E51 - E51
[5] Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Becker, Russell E. N.
Baras, Alex
Bivalacqua, Trinity J.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E58 - E59
[6] Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean FP Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer
Lestingi, Jean F. P.
Quoc-Dien Trinh
Coelho, Rafael F.
Pontes, Jose, Jr.
Bastos, Diogo A.
Nahas, William C.
[J]. EUROPEAN UROLOGY, 2021, 79 (06) : E184 - E185

← 1 →